Physician profile
Alice Wei
NPI 1881626737
$9,884.39
in general payments reported to CMS, 2019-2025
11 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $549 · 2021: $4,213 · 2022: $260 · 2023: $157 · 2024: $4,022 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,400 · Food and Beverage: $1,150 · Travel and Lodging: $732 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,400.00 |
| Food and Beverage | $1,149.73 |
| Travel and Lodging | $731.55 |
| Education | $108.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $4,363.01 | 2019-2021 | |
| Fresenius USA Marketing, INC. | $3,708.64 | 2024 | |
| Intuitive Surgical, INC. | $826.67 | 2020-2024 | |
| Outset Medical INC | $260.26 | 2022 | |
| Travere Therapeutics, INC. | $211.02 | 2025 | |
| Medtronic, INC. | $156.76 | 2023 | Signia |
| Vifor Pharma, INC. | $125.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $117.34 | 2019 | |
| Amgen INC. | $79.51 | 2019 | |
| Merck Sharp & Dohme LLC | $36.18 | 2024 | Keytruda |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.